Flora Growth Completes Multiple Commercial Cannabis Exports Into New International Markets
-
Flora completed dry cannabis flower commercial exports to
Switzerland and theCzech Republic -
The company also completed its first commercial export of CBD isolate to
the United States
“As our global distribution network continues to evolve, adding these three industry-leading countries to our footprint is a major milestone for Flora,” said
This announcement also marks the launch of Flora’s commercial website where approved buyers can learn about Flora’s cultivation and grow practices, and can also initiate orders for high-THC and high-CBD dry flower as well as derivative products.
The global CBD market is estimated to reach
“We are proud to help increase access to safe, legal CBD and THC to consumers all over the globe,” Merchan added. “We look forward to working closely with our partners in
About
Flora is building a connected, design-led collective of plant-based wellness and lifestyle brands, designed to deliver the most compelling customer experiences in the world, one community at a time. As the operator of one of the largest outdoor cannabis cultivation facilities, Flora leverages natural, cost-effective cultivation practices to supply cannabis derivatives to its commercial, house of brands, and life sciences divisions. Visit www.floragrowth.com or follow @floragrowthcorp on social media for more information.
Cautionary Statement Concerning Forward-Looking Statements
This press release contains ‘‘forward-looking statements,’’ as defined by federal securities laws. Forward-looking statements reflect Flora’s current expectations and projections about future events at the time, and thus involve uncertainty and risk. The words “believe,” “expect,” “anticipate,” “will,” “could,” “would,” “should,” “may,” “plan,” “estimate,” “intend,” “predict,” “potential,” “continue,” and the negatives of these words and other similar expressions generally identify forward looking statements. Such forward-looking statements are subject to various risks and uncertainties, including those described under the section entitled “Risk Factors” in Flora’s Annual Report on Form 20-F filed with the
View source version on businesswire.com: https://www.businesswire.com/news/home/20220926005256/en/
Commercial Wholesale:
James.Williams@floragrowth.com
Investor Relations:
ir@floragrowth.com
Public Relations:
+1 (858) 221-8001
flora@cmwmedia.com
Source: